Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021).

Article  PubMed  Google Scholar 

Anastasiadis, A. & de Reijke, T. M. Best practice in the treatment of non-muscle invasive bladder cancer. Ther. Adv. Urol. 4, 13–32 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Kassouf, W. et al. CUA guidelines on the management of non-muscle invasive bladder cancer. Can. Urol. Assoc. J. 9, E690–E704 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Cumberbatch, M. G. K. et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur. Urol. 74, 784–795 (2018).

Article  PubMed  Google Scholar 

Halaseh, S. A. et al. A review of the etiology and epidemiology of bladder cancer: all you need to know. Cureus 14, e27330 (2022).

PubMed  PubMed Central  Google Scholar 

PDQ Adult Treatment Editorial Board. in PDQ Cancer Information Summaries. Available from https://www.ncbi.nlm.nih.gov/books/NBK66010/ (National Cancer Institute, 2024).

Kirkali, Z. et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 66, 4–34 (2005).

Article  PubMed  Google Scholar 

Cheng, L. et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer 85, 2469–2474 (1999).

Article  PubMed  CAS  Google Scholar 

Subiela, J. D. et al. Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes. Eur. Urol. Focus. 6, 674–682 (2020).

Article  PubMed  Google Scholar 

Herranz, R. et al. Circulating cell-free DNA in liquid biopsies as potential biomarker for bladder cancer: a systematic review. Cancers 13, 1448 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

[No authors listed]. in PDQ Cancer Information Summaries. Available from https://www.ncbi.nlm.nih.gov/books/NBK66044/ (National Cancer Institute, 2024).

Nepple, K. G. & O’Donnell, M. A. The optimal management of T1 high-grade bladder cancer. Can. Urol. Assoc. J. 3, S188–S192 (2009).

Article  PubMed  PubMed Central  Google Scholar 

Llano, A., Chan, A., Kuk, C., Kassouf, W. & Zlotta, A. R. Carcinoma in situ (CIS): is there a difference in efficacy between various BCG strains? a comprehensive review of the literature. Cancers 16, 245 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Isharwal, S. & Konety, B. Non-muscle invasive bladder cancer risk stratification. Indian. J. Urol. 31, 289–296 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Tang, D. H. & Chang, S. S. Management of carcinoma in situ of the bladder: best practice and recent developments. Ther. Adv. Urol. 7, 351–364 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Chun, Y. S., Pawlik, T. M. & Vauthey, J. N. 8th edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann. Surg. Oncol. 25, 845–847 (2018).

Article  PubMed  Google Scholar 

Sylvester, R. J. et al. European Association of Urology (EAU) prognostic factor risk groups for Non-muscle-invasive Bladder Cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines Panel. Eur. Urol. 79, 480–488 (2021).

Article  PubMed  Google Scholar 

Grabe-Heyne, K. et al. Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs. Front. Oncol. 13, 1170124 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur. Urol. 71, 447–461 (2017).

Article  PubMed  Google Scholar 

American Cancer Society. Cancer Facts & Figures 2023. American Cancer Society https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2023/2023-cancer-facts-and-figures.pdf (2023).

Siegel, R. L. et al. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33 (2022).

Article  PubMed  Google Scholar 

Aldousari, S. & Kassouf, W. Update on the management of non-muscle invasive bladder cancer. Can. Urol. Assoc. J. 4, 56–64 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Holmang, S. et al. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J. Urol. 153, 1823–1826 (1995).

Article  PubMed  CAS  Google Scholar 

Chang, S. S. et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J. Urol. 198, 552–559 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Powles, T. et al. Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 244–258 (2022).

Article  PubMed  CAS  Google Scholar 

Woldu, S. L., Bagrodia, A. & Lotan, Y. Guideline of guidelines: non-muscle-invasive bladder cancer. BJU Int. 119, 371–380 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Witjes, J. A. et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur. Urol. 65, 778–792 (2014).

Article  PubMed  Google Scholar 

Korkes, F. & Palou, J. High mortality rates after radical cystectomy: we must have acceptable protocols and consider the rationale of cutaneous ureterostomy for high-risk patients. Int. Braz. J. Urol. 45, 1090–1093 (2019).

Article  PubMed  Google Scholar 

Shinagare, A. B. et al. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor.AJR Am. J. Roentgenol. 196, 117–122 (2011).

Article  PubMed  Google Scholar 

Malayeri, A. A., Pattanayak & Apolo, A. B. Imaging muscle-invasive and metastatic urothelial carcinoma. Curr. Opin. Urol. 25, 441–448 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Nkwam, N. & Chen, T. F. Non-muscle invasive transitional cell carcinoma of the distal ureter and bladder with lung metastasis: a case report and literature review. Int. J. Surg. Case Rep. 4, 382–384 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Xu, T. et al. Distant metastasis without regional progression in non-muscle invasive bladder cancer: case report and pooled analysis of literature. World J. Surg. Oncol. 20, 226 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Flaig, T. W. et al. NCCN guidelines® insights: bladder cancer, version 3.2024. J. Natl Compr. Canc. Netw. 22, 216–225 (2024).

Article  PubMed  CAS  Google Scholar 

Dougherty, D. W. et al. Superficial bladder cancer metastatic to the lungs: two case reports and review of the literature. Urology 73, 210.e3–210.e5 (2009).

Article  PubMed  Google Scholar 

Frydenlund, N. et al. Non-muscle invasive papillary urothelial carcinoma metastatic to the mandible. J. Investig. Med. High. Impact Case Rep. 6, 2324709618806332 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Matthews, N. et al. The clinicopathological features of metastatic superficial papillary bladder cancer. J. Urol. 132, 904–906 (1984).